Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 148

1.

Endoscopic sclerotherapy under balloon-assisted enteroscopy for hemorrhagic jejunal varices after choledocho-jejunostomy.

Takashima K, Matsui S, Komeda Y, Nagai T, Toshiharu S, Kashida H, Kudo M.

Endoscopy. 2019 Aug 21. doi: 10.1055/a-0987-9780. [Epub ahead of print] No abstract available.

PMID:
31434157
2.

Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child-Pugh A Liver Function: A Proof-Of-Concept Study.

Kudo M, Ueshima K, Chan S, Minami T, Chishina H, Aoki T, Takita M, Hagiwara S, Minami Y, Ida H, Takenaka M, Sakurai T, Watanabe T, Morita M, Ogawa C, Wada Y, Ikeda M, Ishii H, Izumi N, Nishida N.

Cancers (Basel). 2019 Jul 31;11(8). pii: E1084. doi: 10.3390/cancers11081084.

3.

Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study.

Ueshima K, Nishida N, Hagiwara S, Aoki T, Minami T, Chishina H, Takita M, Minami Y, Ida H, Takenaka M, Sakurai T, Watanabe T, Morita M, Ogawa C, Hiraoka A, Johnson P, Kudo M.

Cancers (Basel). 2019 Jul 7;11(7). pii: E952. doi: 10.3390/cancers11070952.

4.

RICK/RIP2 is a NOD2-independent nodal point of gut inflammation.

Watanabe T, Minaga K, Kamata K, Sakurai T, Komeda Y, Nagai T, Kitani A, Tajima M, Fuss IJ, Kudo M, Strober W.

Int Immunol. 2019 May 27. pii: dxz045. doi: 10.1093/intimm/dxz045. [Epub ahead of print]

PMID:
31132297
5.

Contrast-enhanced harmonic endoscopic ultrasonography for evaluating the response to chemotherapy in pancreatic cancer.

Tanaka H, Kamata K, Takenaka M, Yoshikawa T, Ishikawa R, Okamoto A, Yamazaki T, Nakai A, Omoto S, Minaga K, Yamao K, Sakurai T, Watanabe T, Nishida N, Chiba Y, Kitano M, Kudo M.

Dig Liver Dis. 2019 Aug;51(8):1130-1134. doi: 10.1016/j.dld.2019.03.015. Epub 2019 Apr 19.

PMID:
31006543
6.

Usefulness of Ustekinumab for Treating a Case of Myelodysplastic Syndrome-associated Inflammatory Bowel Disease.

Kono M, Sakurai T, Okamoto K, Nagai T, Komeda Y, Kashida H, Minaga K, Kamata K, Takenaka M, Hagiwara S, Watanabe T, Nishida N, Enoki E, Inoue H, Matsumura I, Kudo M.

Intern Med. 2019 Jul 15;58(14):2029-2033. doi: 10.2169/internalmedicine.2495-18. Epub 2019 Apr 17.

7.

Clinical Safety and Efficacy of Secondary Prophylactic Pegylated G-CSF in Advanced Pancreatic Cancer Patients Treated with mFOLFIRINOX: A Single-center Retrospective Study.

Yamao K, Takenaka M, Yoshikawa T, Ishikawa R, Okamoto A, Yamazaki T, Nakai A, Omoto S, Kamata K, Minaga K, Hagiwara S, Sakurai T, Nishida N, Chiba Y, Watanabe T, Kudo M.

Intern Med. 2019 Jul 15;58(14):1993-2002. doi: 10.2169/internalmedicine.2234-18. Epub 2019 Apr 17.

8.

Risk factors for local recurrence and appropriate surveillance interval after endoscopic resection.

Komeda Y, Watanabe T, Sakurai T, Kono M, Okamoto K, Nagai T, Takenaka M, Hagiwara S, Matsui S, Nishida N, Tsuji N, Kashida H, Kudo M.

World J Gastroenterol. 2019 Mar 28;25(12):1502-1512. doi: 10.3748/wjg.v25.i12.1502.

9.

Efficacy and Safety of Chemotherapy Following Anti-PD-1 Antibody Therapy for Gastric Cancer: A Case of Sclerosing Cholangitis.

Kono M, Sakurai T, Okamoto K, Masaki S, Nagai T, Komeda Y, Kamata K, Minaga K, Yamao K, Takenaka M, Watanabe T, Nishida N, Kudo M.

Intern Med. 2019 May 1;58(9):1263-1266. doi: 10.2169/internalmedicine.1981-18. Epub 2019 Jan 10.

10.

Gankyrin Contributes to Tumorigenesis and Chemoresistance in Sporadic Colorectal Cancer.

Sakurai T, Komeda Y, Nagai T, Kamata K, Minaga K, Yamao K, Takenaka M, Hagiwara S, Watanabe T, Nishida N, Kashida H, Nakagawa K, Kudo M.

Digestion. 2018 Dec 4:1-9. doi: 10.1159/000494969. [Epub ahead of print]

PMID:
30513515
11.

A case of small invasive gastric cancer arising from Helicobacter pylori-negative gastric mucosa: Fundic gland-type adenocarcinoma.

Komeda Y, Watanabe T, Matsui S, Kashida H, Sakurai T, Kono M, Minaga K, Nagai T, Hagiwara S, Enoki E, Kudo M.

JGH Open. 2017 Oct 12;1(2):74-75. doi: 10.1002/jgh3.12011. eCollection 2017 Oct.

12.

Molecular Scoring of Hepatocellular Carcinoma for Predicting Metastatic Recurrence and Requirements of Systemic Chemotherapy.

Nishida N, Nishimura T, Kaido T, Minaga K, Yamao K, Kamata K, Takenaka M, Ida H, Hagiwara S, Minami Y, Sakurai T, Watanabe T, Kudo M.

Cancers (Basel). 2018 Sep 29;10(10). pii: E367. doi: 10.3390/cancers10100367.

13.

Erythropoietic Protoporphyria-related Hepatopathy Successfully Treated with Phlebotomy.

Yoshida A, Hagiwara S, Watanabe T, Nishida N, Ida H, Sakurai T, Komeda Y, Yamao K, Takenaka M, Enoki E, Kimura M, Miyake M, Kawada A, Kudo M.

Intern Med. 2018;57(17):2505-2509. doi: 10.2169/internalmedicine.0673-17. Epub 2018 Sep 1.

14.

Pilot study of WT1 peptide-pulsed dendritic cell vaccination with docetaxel in esophageal cancer.

Matsuda T, Takeuchi H, Sakurai T, Mayanagi S, Booka E, Fujita T, Higuchi H, Taguchi J, Hamamoto Y, Takaishi H, Kawakubo H, Okamoto M, Sunamura M, Kawakami Y, Kitagawa Y.

Oncol Lett. 2018 Jul;16(1):1348-1356. doi: 10.3892/ol.2018.8734. Epub 2018 May 17.

15.

Dysbiosis-Associated Polyposis of the Colon-Cap Polyposis.

Okamoto K, Watanabe T, Komeda Y, Okamoto A, Minaga K, Kamata K, Yamao K, Takenaka M, Hagiwara S, Sakurai T, Tanaka T, Sakamoto H, Fujimoto K, Nishida N, Kudo M.

Front Immunol. 2018 May 7;9:918. doi: 10.3389/fimmu.2018.00918. eCollection 2018.

16.

Cystic duct antegrade stenting for cholangitis after the long-term deployment of lumen-apposing metal stents for calculous cholecystitis.

Kamata K, Takenaka M, Minaga K, Nakai A, Omoto S, Miyata T, Yamao K, Imai H, Sakurai T, Watanabe T, Nishida N, Kudo M.

Endosc Ultrasound. 2018 Sep-Oct;7(5):349-350. doi: 10.4103/eus.eus_91_17. No abstract available.

17.

Value of additional endoscopic ultrasonography for surveillance after surgical removal of intraductal papillary mucinous neoplasms.

Kamata K, Takenaka M, Minaga K, Omoto S, Miyata T, Yamao K, Imai H, Nakai A, Tanaka H, Chiba Y, Watanabe T, Sakurai T, Nishida N, Chikugo T, Matsumoto I, Takeyama Y, Kitano M, Kudo M.

Dig Endosc. 2018 Sep;30(5):659-666. doi: 10.1111/den.13176. Epub 2018 May 16.

PMID:
29675938
18.

Sustained antiviral effects and clearance of hepatitis surface antigen after combination therapy with entecavir and pegylated interferon in chronic hepatitis B.

Hagiwara S, Nishida N, Watanabe T, Ida H, Sakurai T, Ueshima K, Takita M, Komeda Y, Nishijima N, Osaki Y, Kudo M.

Antivir Ther. 2018;23(6):513-521. doi: 10.3851/IMP3225.

PMID:
29438098
19.

Outcomes of endoscopic biliary drainage in pancreatic cancer patients with an indwelling gastroduodenal stent: a multicenter cohort study in West Japan.

Yamao K, Kitano M, Takenaka M, Minaga K, Sakurai T, Watanabe T, Kayahara T, Yoshikawa T, Yamashita Y, Asada M, Okabe Y, Hanada K, Chiba Y, Kudo M.

Gastrointest Endosc. 2018 Jul;88(1):66-75.e2. doi: 10.1016/j.gie.2018.01.021. Epub 2018 Jan 31.

PMID:
29382465
20.

Association between the Risk Factors for Pancreatic Ductal Adenocarcinoma and Those for Malignant Intraductal Papillary Mucinous Neoplasm.

Kamata K, Takenaka M, Nakai A, Omoto S, Miyata T, Minaga K, Matsuda T, Yamao K, Imai H, Chiba Y, Sakurai T, Watanabe T, Nishida N, Chikugo T, Matsumoto I, Takeyama Y, Kudo M.

Oncology. 2017;93 Suppl 1:102-106. doi: 10.1159/000481234. Epub 2017 Dec 20.

Supplemental Content

Loading ...
Support Center